Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Platten

Showing results (241-250 of 318) with videos related to

Pageof 32
Sort By:
Neurology|May 12, 2019
Imaging necrosis during treatment is associated with worse survival in EORTC 26101 studyMartha Nowosielski, Thierry Gorlia, Jacoline E C Bromberg, et al.
Oncoimmunology|March 28, 2017
Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancerDyah L Dewi, Soumya R Mohapatra, Saioa Blanco Cabañes, et al.
Journal for Immunotherapy of Cancer|July 3, 2021
Systematic review of combinations of targeted or immunotherapy in advanced solid tumorsAaron C Tan, Stephen J Bagley, Patrick Y Wen, et al.
Neuro-Oncology|February 18, 2020
Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytomaAntje Wick, Tobias Kessler, Michael Platten, et al.
Nature Aging|June 4, 2024
Cell type mapping of inflammatory muscle diseases highlights selective myofiber vulnerability in inclusion body myositisSven Wischnewski, Thomas Thäwel, Chiseko Ikenaga, et al.
Neurological Research and Practice|October 18, 2023
INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomasNiklas Grassl, Katharina Sahm, Heike Süße, et al.
Neuro-Oncology|April 19, 2013
Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collectiveBenedikt Wiestler, Rainer Claus, Sabine A Hartlieb, et al.
Frontiers in Immunology|January 19, 2024
MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detectionMarten Meyer, Christina Parpoulas, Titouan Barthélémy, et al.
Acta Neuropathologica|October 25, 2013
Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous systemChristian Koelsche, Felix Sahm, David Capper, et al.
The New England Journal of Medicine|November 16, 2017
Lomustine and Bevacizumab in Progressive GlioblastomaWolfgang Wick, Thierry Gorlia, Martin Bendszus, et al.
Pageof 32

Showing results (241-250 of 318) with videos related to

Sort By:
Pageof 32
Neurology|May 12, 2019
Imaging necrosis during treatment is associated with worse survival in EORTC 26101 studyMartha Nowosielski, Thierry Gorlia, Jacoline E C Bromberg, et al.
Oncoimmunology|March 28, 2017
Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancerDyah L Dewi, Soumya R Mohapatra, Saioa Blanco Cabañes, et al.
Journal for Immunotherapy of Cancer|July 3, 2021
Systematic review of combinations of targeted or immunotherapy in advanced solid tumorsAaron C Tan, Stephen J Bagley, Patrick Y Wen, et al.
Neuro-Oncology|February 18, 2020
Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytomaAntje Wick, Tobias Kessler, Michael Platten, et al.
Nature Aging|June 4, 2024
Cell type mapping of inflammatory muscle diseases highlights selective myofiber vulnerability in inclusion body myositisSven Wischnewski, Thomas Thäwel, Chiseko Ikenaga, et al.
Neurological Research and Practice|October 18, 2023
INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomasNiklas Grassl, Katharina Sahm, Heike Süße, et al.
Neuro-Oncology|April 19, 2013
Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collectiveBenedikt Wiestler, Rainer Claus, Sabine A Hartlieb, et al.
Frontiers in Immunology|January 19, 2024
MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detectionMarten Meyer, Christina Parpoulas, Titouan Barthélémy, et al.
Acta Neuropathologica|October 25, 2013
Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous systemChristian Koelsche, Felix Sahm, David Capper, et al.
The New England Journal of Medicine|November 16, 2017
Lomustine and Bevacizumab in Progressive GlioblastomaWolfgang Wick, Thierry Gorlia, Martin Bendszus, et al.
Pageof 32